MedTrace Logo

the Efficacy and Safety of the 3-steps Conservative Approach in the Management of Placenta Accreta Spectrum (a Novel Technique)

NCT05191316 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 28

Last updated 2022-01-13

No results posted yet for this study

Summary

Placenta accrete spectrum (PAS) is an heterogeneous condition associated with a high maternal morbidity and mortality rate, presenting unique challenges in its diagnosis and management (Morlandoi et al., 2020). PAS describes a clinical situation where the placenta does not detach spontaneously after delivery and cannot be forcibly removed without causing massive and potentially life-threatening bleeding (Jauniaux et al., 2018), in this study we study a novel 3-step technique for surgical conservative management of PAS, in terms of efficacy and safety.

Conditions

  • Placenta Accreta, Third Trimester

Sponsors & Collaborators

  • Cairo University

    lead OTHER

Principal Investigators

  • Hassan M Gaafar, M.D · prof. of obstetrics and gynecology (Faculty of medicine -Cairo university)

  • Moataz M El-sherbini, M.D · prof. of obstetrics and gynecology (Faculty of medicine -Cairo university)

  • Abdalla m Mousa, M.D · lecturer of obstetrics and gynecology (Faculty of medicine -Cairo university)

  • mostafa E Abdalla, MRCOG · Senior specialist clinical fellow, gynecology Guy's and St. Thomas's NHS TRUST

  • Mazen m Abdel-rasheed, PhD · reproductive health research department, national research centre

  • sondos m salem, PhD · reproductive health research department, national research centre

Eligibility

Min Age
20 Years
Max Age
40 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-02-15
Primary Completion
2022-04-15
Completion
2022-05-15

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05191316 on ClinicalTrials.gov